Archives
-
Protease Inhibitor Cocktail in Ataxin-3 Studies
2026-09-13
Mechanistic studies of the Ataxin-3–CFTR axis show why sample handling is part of translational rigor. An EDTA-free, broad-spectrum protease inhibitor strategy can help preserve protein abundance and interaction readouts without compromising divalent-cation-dependent assays.
-
Anti-RPS6 Antibody Workflows for PDAC Research
2026-09-12
Build reproducible Western blot, immunofluorescence, and immunoprecipitation workflows around total RPS6 to connect ribosome biology with KRAS/EGFR-driven pancreatic cancer phenotypes. This practical guide shows how to use MA4974 for pathway-aware assay design, model comparison, and troubleshooting rather than treating RPS6 abundance as a standalone activity marker.
-
Indomethacin A8449: Practical Research Workflow
2026-09-11
Indomethacin A8449 provides a defined perturbation tool for COX-focused inflammation research, with additional use in PPAR-linked lipid metabolism study and membrane signaling modulation. It is appropriate for controlled biochemical, cellular, and exploratory mechanism assays, but it should not be treated as a pathway-specific probe or assigned paper-level dosing outcomes without assay-specific validation.
-
Phosbind Biotin: Phosphorylation Workflow
2026-09-11
Phosbind Biotin enables sequence-independent Western Blot detection of phosphorylated proteins when a suitable phospho-specific antibody is unavailable or too narrow. This workflow translates the OsCPK4–OsCNGC7 rice salt-response model into practical time-course, control, and troubleshooting strategies for protein phosphorylation analysis.
-
Plant Cell Lysis Buffer for WB and IP
2026-09-10
This scenario-based guide shows how Plant Cell Lysis Buffer for WB and IP, SKU K1126, can support reproducible protein extraction after plant, microbial, or animal-cell assays. It connects practical Western blotting and immunoprecipitation decisions with evidence from the MAPK10–KRT16 metastasis study while separating product capabilities from disease-specific conclusions.
-
Phenytoin: Sodium Channel Assay Workflows
2026-09-10
Phenytoin supports controlled sodium channel modulation research while also enabling an orthogonal enzyme-inhibition workflow based on paraoxonase-1. This guide combines solvent-aware preparation, electrophysiology assay design, reference-backed PON1 kinetics, and troubleshooting for reproducible experiments.
-
G-15: A G Protein-Coupled Estrogen Receptor Antagonist
2026-09-09
G-15 enables controlled dissection of GPR30/GPER signaling in calcium, PI3K/Akt, proliferation, and neurobiology experiments. This workflow-focused guide explains how to use its receptor selectivity, solvent properties, and antagonist controls to distinguish pathway-specific effects from assay artifacts.
-
Lambda Protein Phosphatase for BMAL1 Validation
2026-09-09
Use Lambda Protein Phosphatase as a controlled dephosphorylation switch for BMAL1 condensate studies, antibody validation, and phosphorylation-dependent functional assays. Its broad dual-specificity activity and RNase-free formulation help separate genuine phosphoregulation from detection artifacts and sample degradation.
-
Prednisolone B2012: Reliable Cell Assays
2026-09-08
Learn how Prednisolone (SKU B2012) can improve control of glucocorticoid exposure in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solvent selection, stock preparation, assay interpretation, vendor reliability, and the limits of extending glucocorticoid studies into ERAD research.
-
L-NMMA Acetate: Designing Causal NO Assays
2026-09-08
L-NMMA acetate enables controlled interrogation of nitric oxide synthase biology. This article presents a causality-centered assay framework, using dental follicle osteogenesis research to explain how inhibitor choice, orthogonal readouts, and experimental timing improve interpretation.
-
Y-27632 ROCK Inhibitor Workflow for hiPSC Models
2026-09-07
Use Y-27632 as a timed, reversible ROCK inhibitor to tune attachment, actin organization, and cytoskeletal stress in human cell assays. Its value is especially clear when applied alongside genetically defined hiPSC resources, where morphology and survival controls help separate cytoskeletal effects from disease-linked phenotypes.
-
AZD6482 PI3Kβ Inhibitor Workflows
2026-09-07
AZD6482 combines nanomolar biochemical potency with PI3Kβ selectivity for platelet, metabolic, and pathway-perturbation studies. This workflow shows how to connect dose control, RNA-FISH-style phenotyping, and orthogonal signaling assays without confusing exploratory cross-domain findings with established DM1 biology.
-
SB 431542 Workflow for TGF-β Mechanism Studies
2026-09-05
SB 431542 provides a practical way to test whether ALK5-dependent TGF-β signaling links inflammatory cell communication to neuronal injury, proliferation changes, or immune phenotypes. This workflow combines Smad2 target engagement, exosome-aware controls, and functional validation so pathway inhibition is not mistaken for nonspecific toxicity.
-
Dibutyryl-cAMP in Astrocyte Reprogramming Assays
2026-09-04
Dibutyryl-cAMP, sodium salt is a cell-permeable cAMP analog for testing how PKA-linked signaling reshapes astrocyte-to-motoneuron reprogramming. This article connects the compound’s assay utility with the stage-resolved findings of the 4F transcription-factor study while defining practical controls and limitations.
-
CerS6, Ceramide, and Stress-Induced Liver Injury
2026-09-04
Liu et al. identify CerS6-derived C16:0 ceramide as a mechanistic link between corticosterone-associated stress signaling and mitochondrial injury in rat hepatocytes. Their combined restraint-stress, hepatocyte, lipidomic, pathway-inhibition, and gene-knockdown approach supports an AMPK/p38 MAPK–CerS6 axis with implications for studying stress-related hepatic damage.